Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
- PMID: 27797957
- DOI: 10.1126/scitranslmed.aaf9246
Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
Erratum in
-
Erratum for the Perspective: "Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action" by Y. Pommier, M. J. O'Connor, J. de Bono.Sci Transl Med. 2016 Dec 7;8(368):368er7. doi: 10.1126/scitranslmed.aal4973. Sci Transl Med. 2016. PMID: 27928024 No abstract available.
Abstract
Poly(ADP-ribose) polymerase (PARP) inhibitors are the first DNA damage response targeted agents approved for cancer therapy. Here, we focus on their molecular mechanism of action by PARP "trapping" and what this means for both clinical monotherapy and combination with chemotherapeutic agents.
Copyright © 2016, American Association for the Advancement of Science.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
